129 related articles for article (PubMed ID: 36259160)
21. Association Between Specific Mutations in KRAS Codon 12 and Colorectal Liver Metastasis.
Margonis GA; Kim Y; Spolverato G; Ejaz A; Gupta R; Cosgrove D; Anders R; Karagkounis G; Choti MA; Pawlik TM
JAMA Surg; 2015 Aug; 150(8):722-9. PubMed ID: 26038887
[TBL] [Abstract][Full Text] [Related]
22. The prognosis of colorectal cancer liver metastases associated with inflammatory bowel disease: An exploratory analysis.
Margonis GA; Buettner S; Andreatos N; Wagner D; Sasaki K; Galjart B; Kamphues C; Pawlik TM; Poultsides G; Kaczirek K; Lønning PE; Verhoef C; Kreis ME; Wolfgang CL; Weiss MJ
J Surg Oncol; 2018 Dec; 118(7):1074-1080. PubMed ID: 30261094
[TBL] [Abstract][Full Text] [Related]
23. Chemotherapy and targeted therapy for patients with initially unresectable colorectal liver metastases, focusing on conversion hepatectomy and long-term survival.
Beppu T; Miyamoto Y; Sakamoto Y; Imai K; Nitta H; Hayashi H; Chikamoto A; Watanabe M; Ishiko T; Baba H
Ann Surg Oncol; 2014 Jun; 21 Suppl 3():S405-13. PubMed ID: 24570379
[TBL] [Abstract][Full Text] [Related]
24. The impact of primary tumour location in patients undergoing hepatic resection for colorectal liver metastasis.
Wang K; Xu D; Yan XL; Poston G; Xing BC
Eur J Surg Oncol; 2018 Jun; 44(6):771-777. PubMed ID: 29580735
[TBL] [Abstract][Full Text] [Related]
25. Prognostic impact of positive surgical margins after resection of colorectal cancer liver metastases: reappraisal in the era of modern chemotherapy.
Tranchart H; Chirica M; Faron M; Balladur P; Lefevre LB; Svrcek M; de Gramont A; Tiret E; Paye F
World J Surg; 2013 Nov; 37(11):2647-54. PubMed ID: 23982776
[TBL] [Abstract][Full Text] [Related]
26. Is Hepatectomy Justified for BRAF Mutant Colorectal Liver Metastases?: A Multi-institutional Analysis of 1497 Patients.
Gagnière J; Dupré A; Gholami SS; Pezet D; Boerner T; Gönen M; Kingham TP; Allen PJ; Balachandran VP; De Matteo RP; Drebin JA; Yaeger R; Kemeny NE; Jarnagin WR; D'Angelica MI
Ann Surg; 2020 Jan; 271(1):147-154. PubMed ID: 29995686
[TBL] [Abstract][Full Text] [Related]
27. Adjuvant hepatic arterial infusion pump chemotherapy and resection versus resection alone in patients with low-risk resectable colorectal liver metastases - the multicenter randomized controlled PUMP trial.
Buisman FE; Homs MYV; Grünhagen DJ; Filipe WF; Bennink RJ; Besselink MGH; Borel Rinkes IHM; Bruijnen RCG; Cercek A; D'Angelica MI; van Delden OM; Donswijk ML; van Doorn L; Doornebosch PG; Emmering J; Erdmann JI; IJzerman NS; Grootscholten C; Hagendoorn J; Kemeny NE; Kingham TP; Klompenhouwer EG; Kok NFM; Koolen S; Kuhlmann KFD; Kuiper MC; Lam MGE; Mathijssen RHJ; Moelker A; Oomen-de Hoop E; Punt CJA; Te Riele WW; Roodhart JML; Swijnenburg RJ; Prevoo W; Tanis PJ; Vermaas M; Versleijen MWJ; Veuger FP; Weterman MJ; Verhoef C; Groot Koerkamp B
BMC Cancer; 2019 Apr; 19(1):327. PubMed ID: 30953467
[TBL] [Abstract][Full Text] [Related]
28. The prognostic value of preoperative serum lactate dehydrogenase levels in patients underwent curative-intent hepatectomy for colorectal liver metastases: A two-center cohort study.
Bai L; Lin ZY; Lu YX; Chen Q; Zhou H; Meng Q; Lin CP; Huang WL; Wan YL; Pan ZZ; Wang DS
Cancer Med; 2021 Nov; 10(22):8005-8019. PubMed ID: 34636145
[TBL] [Abstract][Full Text] [Related]
29. Codon 13 KRAS mutation predicts patterns of recurrence in patients undergoing hepatectomy for colorectal liver metastases.
Margonis GA; Kim Y; Sasaki K; Samaha M; Amini N; Pawlik TM
Cancer; 2016 Sep; 122(17):2698-707. PubMed ID: 27244540
[TBL] [Abstract][Full Text] [Related]
30. Effect of KRAS Mutation on Long-Term Outcomes of Patients Undergoing Hepatic Resection for Colorectal Liver Metastases.
Margonis GA; Spolverato G; Kim Y; Karagkounis G; Choti MA; Pawlik TM
Ann Surg Oncol; 2015 Dec; 22(13):4158-65. PubMed ID: 26077912
[TBL] [Abstract][Full Text] [Related]
31. Association of BRAF Mutations With Survival and Recurrence in Surgically Treated Patients With Metastatic Colorectal Liver Cancer.
Margonis GA; Buettner S; Andreatos N; Kim Y; Wagner D; Sasaki K; Beer A; Schwarz C; Løes IM; Smolle M; Kamphues C; He J; Pawlik TM; Kaczirek K; Poultsides G; Lønning PE; Cameron JL; Burkhart RA; Gerger A; Aucejo FN; Kreis ME; Wolfgang CL; Weiss MJ
JAMA Surg; 2018 Jul; 153(7):e180996. PubMed ID: 29799910
[TBL] [Abstract][Full Text] [Related]
32. Potential for cure and predictors of long-term survival after radiofrequency ablation for colorectal liver metastases: A 20-years single-center experience.
Weilert H; Sadeghi D; Lipp M; Oldhafer KJ; Donati M; Stang A
Eur J Surg Oncol; 2022 Dec; 48(12):2487-2494. PubMed ID: 35718675
[TBL] [Abstract][Full Text] [Related]
33. Effect of Neoadjuvant Chemotherapy in Patients with Colorectal Cancer Liver Metastases.
Sui K; Okabayashi T; Iwata J; Morita SM; Matsumoto T; Inada R; Iiyama T; Shimada Y; Kobayashi M
Surg Technol Int; 2019 May; 34():208-214. PubMed ID: 31037714
[TBL] [Abstract][Full Text] [Related]
34. Effect of high ligation on survival of patients undergoing surgery for primary colorectal cancer and synchronous liver metastases.
Matsui S; Okabayashi K; Hasegawa H; Tsuruta M; Shigeta K; Ishida T; Yamada T; Kondo T; Yamauchi S; Sugihara K; Kitagawa Y
BJS Open; 2020 Jun; 4(3):508-515. PubMed ID: 32243733
[TBL] [Abstract][Full Text] [Related]
35. Prognostic Value of Poorly Differentiated Clusters in Liver Metastatic Lesions of Colorectal Carcinoma.
Yonemura K; Kajiwara Y; Ao T; Mochizuki S; Shinto E; Okamoto K; Hase K; Ueno H
Am J Surg Pathol; 2019 Oct; 43(10):1341-1348. PubMed ID: 31318710
[TBL] [Abstract][Full Text] [Related]
36. Significance of Herpesvirus Entry Mediator Expression in Human Colorectal Liver Metastasis.
Sasaki Y; Hokuto D; Inoue T; Nomi T; Yoshikawa T; Matsuo Y; Koyama F; Sho M
Ann Surg Oncol; 2019 Nov; 26(12):3982-3989. PubMed ID: 31313042
[TBL] [Abstract][Full Text] [Related]
37. Rescue surgery for unresectable colorectal liver metastases downstaged by chemotherapy: a model to predict long-term survival.
Adam R; Delvart V; Pascal G; Valeanu A; Castaing D; Azoulay D; Giacchetti S; Paule B; Kunstlinger F; Ghémard O; Levi F; Bismuth H
Ann Surg; 2004 Oct; 240(4):644-57; discussion 657-8. PubMed ID: 15383792
[TBL] [Abstract][Full Text] [Related]
38. Impact of Surgical Treatment for Recurrence After 2-Stage Hepatectomy for Colorectal Liver Metastases, on Patient Outcome.
Imai K; Benitez CC; Allard MA; Vibert E; Cunha AS; Cherqui D; Castaing D; Bismuth H; Baba H; Adam R
Ann Surg; 2019 Feb; 269(2):322-330. PubMed ID: 28820745
[TBL] [Abstract][Full Text] [Related]
39. Prognostic impact of conversion hepatectomy for initially unresectable colorectal liver metastasis.
Takamizawa Y; Inoue M; Moritani K; Tsukamoto S; Esaki M; Shimada K; Kanemitsu Y
Langenbecks Arch Surg; 2022 Nov; 407(7):2893-2903. PubMed ID: 36068379
[TBL] [Abstract][Full Text] [Related]
40. Total tumour volume as a prognostic factor in patients with resectable colorectal cancer liver metastases.
Tai K; Komatsu S; Sofue K; Kido M; Tanaka M; Kuramitsu K; Awazu M; Gon H; Tsugawa D; Yanagimoto H; Toyama H; Murakami S; Murakami T; Fukumoto T
BJS Open; 2020 Jun; 4(3):456-466. PubMed ID: 32277807
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]